Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 236

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Interleukin‐6 and type I interferon–regulated genes and chemokines mark disease activity in dermatomyositis

Bilgic, Hatice, Ytterberg, Steven R., Amin, Shreyasee, McNallan, Kelly T., Wilson, Joseph C., Koeuth, Thearith, Ellingson, Sonja, Newman, Brant, Bauer, Jason W., Peterson, Erik J., Baechler, Emily C., Reed, Ann M. · 2009 · Arthritis & Rheumatism

Abstract

Objective: Up‐regulation of whole blood type I interferon (IFN)–driven transcripts and chemokines has been described in a number of autoimmune diseases. An IFN gene expression “signature” is a candidate biomarker in patients with dermatomyositis (DM). This study was performed to evaluate the capacity of IFN‐dependent peripheral blood gene and chemokine signatures and levels of proinflammatory cytokines to serve as biomarkers for disease activity in adult and juvenile DM. Methods: Peripheral blood samples and clinical data were obtained from 56 patients with adult or juvenile DM. The type I IFN gene signature in the whole blood of patients with DM was defined by determining the expression levels of 3 IFN‐regulated genes (IFIT1, G1P2, and IRF7) using quantitative real‐time reverse transcription–polymerase chain reaction. Multiplexed immunoassays were used to quantify the serum levels of 4 type I IFN–regulated chemokines (IFN‐inducible T cell α chemoattractant, IFNγ‐inducible 10‐kd protein, monocyte chemotactic protein 1 [MCP‐1], and MCP‐2) and the serum levels of other proinflammatory cytokines, including interleukin‐6 (IL‐6). Results: DM disease activity correlated significantly with the type I IFN gene signature (r = 0.41, P = 0.007) and with the type I IFN chemokine signature (r = 0.61, P < 0.0001). Furthermore, the serum levels of IL‐6 were significantly correlated with disease activity (r = 0.45, P = 0.001). In addition, correlations between the serum levels of IL‐6 and both the type I IFN gene signature (r = 0.47, P < 0.01) and the type I IFN chemokine signature (r = 0.71, P < 0.0001) were detected in patients with DM. Conclusion: These results suggest that serum IL‐6 production and the type I IFN gene signature are candidate biomarkers for disease activity in adult and juvenile DM. Coregulation of the expression of IFN‐driven chemokines and IL‐6 suggests a novel pathogenic linkage in DM.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.24936

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 236

Metadata

Authors
Bilgic, H., Ytterberg, S. R., Amin, S., McNallan, K. T., Wilson, J. C., Koeuth, T., Ellingson, S., Newman, B., Bauer, J. W., Peterson, E. J., Baechler, E. C., & Reed, A. M.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2009-10-29
Volume
60
Issue
11
Pages
3436-3446
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2042615668
Cited by
236
References
2
FWCI
9.05
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Interleukin‐6 and type I interferon–regulated genes and chemokines mark disease activity in dermatomyositis. https://app.cochat.ai/papers/10.1002/art.24936
The paper
Bilgic, H., Ytterberg, S. R., Amin, S., McNallan, K. T., Wilson, J. C., Koeuth, T., Ellingson, S., Newman, B., Bauer, J. W., Peterson, E. J., Baechler, E. C., & Reed, A. M. (2009). Interleukin‐6 and type I interferon–regulated genes and chemokines mark disease activity in dermatomyositis. Arthritis & Rheumatism. https://doi.org/10.1002/art.24936

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.